The clinical and radiographic importance of distinguishing partial from near-complete reperfusion following intra-arterial stroke therapy

American Journal of Neuroradiology

Volumn 34, Issue 1, 2013, Pages 135-139

  Jayaraman, M V ^a,b   Grossberg, J A ^b   Meisel, K M ^a   Shaikhouni, A ^b   Silver, B ^a  

^a BROWN UNIVERSITY   (United States)

^b Brown University Program in Neurosurgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; REPERFUSION INJURY;

AGED; CEREBRAL ANGIOGRAPHY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; PERFUSION IMAGING; REPERFUSION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STROKE; THROMBECTOMY; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84873662910     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3278     Document Type: Article

References (22)

1. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: thePROACTII study: a randomized controlled trial - Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11
2. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke - PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4-11
3. Flint AC, Duckwiler GR, Budzik RF, et al. Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials. Stroke 2007;38:1274-80
4. Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-68
5. Ogawa A, Mori E, Minematsu K, et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007;38:2633-39
6. Nogueira RG, Liebeskind DS, Sung G, et al. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke 2009;40: 3777-83
7. Higashida RT, Furlan AJ, Roberts H, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109-137
8. Kasner SE, Cucchiara BL, McGarvey ML, et al. Modified National Institutes of Health Stroke Scale can be estimated from medical records. Stroke 2003;34:568-70
9. Berger C, Fiorelli M, Steiner T, et al. Hemorrhagic transformation ofischemic brain tissue: asymptomatic or symptomatic? Stroke 2001;32:1330-35
10. Fiorelli M, Bastianello S, von Kummer R, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999;30:2280-84
11. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25
12. Tomsick T, Broderick J, Carrozella J, et al. Revascularization results in the Interventional Management of Stroke II Trial. AJNR Am J Neuroradiol 2008;29:582-87
13. Arnold M, Nedeltchev K, Remonda L, et al. Recanalisation of middle cerebral artery occlusion after intra-arterial thrombolysis: different recanalisation grading systems and clinical functional outcome. J Neurol Neurosurg Psychiatry 2005;76:1373-76
14. Fields JD, Lutsep HL, Smith WS. Higher degrees of recanalization after mechanical thrombectomy for acute stroke are associated with improved outcome and decreased mortality: pooled analysis of the MERCI and Multi MERCI Trials. AJNR Am J Neuroradiol 2011;32:2170-74
15. Yoo AJ, Verduzco LA, Schaefer PW, et al. MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusionweighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke 2009; 40:2046-54
16. Parsons MW, Christensen S, McElduff P, et al. Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab 2010;30:1214-25
17. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508-17
18. Shaltoni HM, Albright KC, Gonzales NR, et al. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke 2007;38: 80-84
19. Tomsick T. TIMI, TIBI, TICI: I came, I saw, I got confused. AJNR Am J Neuroradiol 2007;28:382-84
20. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205-12
21. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: EmergencyManagementof Stroke (EMS) Bridging Trial. Stroke 1999;30:2598-605
22. IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke 2007;38:2127-35